Female Infertility.
Conditions
Interventions
Intervention 1: In the control group: Endometrial preparation starts with the Estradiol valerate 4 mg tablet once a day and after three days to 6 mg per day increases. Endometrial thickness is determi
Treatment - Drugs
In the control group: Endometrial preparation starts with the Estradiol valerate 4 mg tablet once a day and after three days to 6 mg per day increases. Endometrial thickness is determined by ultrasoun
In the case group: Before progesterone injection in study group 100 micrograms G-CSF with IUI catheter as infusion intrauterine. Three days after the injection of progesterone transferred embryo
Sponsors
Vice chancellor for Research,Tabriz University Of Medical Sciences
Eligibility
Sex/Gender
Female
Age
18 Years to 45 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: Age 45-18 , and personal satisfaction; Had two or more failures of implantation Exclusion criteria: patients with a history of uterine surgery; hydrosalpinges; endometriosis; Endometrial polyps; Submucosal myoma; Contraindications G-CSF as:Kidney failure; Chronic Neutropenia;anemia; Cancer; Pneumonia.
Exclusion criteria
Exclusion criteria:
Design outcomes
Secondary
| Measure | Time frame |
|---|---|
| Clinical pregnancy. Timepoint: Two weeks after positive BHCG. Method of measurement: Vaginal ultrasound. | — |
Primary
| Measure | Time frame |
|---|---|
| Implantation rates. Timepoint: Two weeks after embryo transfer. Method of measurement: Ultrasound. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr.Farzadi Laaya
Tabriz University Of Medical Sciences
Outcome results
None listed